Learn about the link between lichen sclerosus and vulvar cancer, including the possible causes, risk factors, symptoms to watch out for, and treatment options.

Lichen sclerosus primarily affects the skin in the genital and anal regions. Estimates of the disease range between 1 in 300 and 1 in 1000 people, according to the US National Institutes of Health.

Of the 30 patients treated solely for lichen sclerosus, 21 showed a response, and 9 had no response. The overall response among those with anogenital lichen sclerosus was 84.6% compared to 50% in ...

A new online guide has been launched to support and empower people with vulval lichen sclerosus (LS) to learn about the condition, access the right treatment and live more comfortably. It is ...

More information: Arabella Crew et al, Barriers to diagnosing and treating vulval lichen sclerosus: a survey study, British Journal of General Practice (2024). DOI: 10.3399/BJGP.2024.0360.

Ruxolitinib cream twice daily resulted in “significant improvements in cutaneous lichen planus disease severity vs vehicle” after 16 weeks of treatment, said the study presenter, Aaron R ...

Researchers find that while clinicians agree on diagnostic and treatment practices for pediatric vulvar and perianal lichen sclerosus, management techniques lack uniformity, according to a study ...